HBV reactivation under immunosuppressive treatment – a case series
| Autor: | Mihaela Rădulescu, Anca-Ruxandra Negru, Aida Adamescu, Smaranda Gliga, Alina Lobodan, Raluca Mihăilescu, Georgiana Juganaru, Daniela Munteanu, Cristina Popescu, Violeta Molagic, Irina Lăpădat, Victoria Aramă, Cătălin Tilişcan |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Immunosuppressive treatment
medicine.medical_specialty Pathology business.industry medicine.medical_treatment Hbv reactivation Liver failure virus diseases Lamivudine Immunosuppression Entecavir digestive system diseases Infectious Diseases Medical microbiology Increased risk Immunology medicine Oral Presentation business medicine.drug |
| Zdroj: | BMC Infectious Diseases |
| ISSN: | 1471-2334 |
| DOI: | 10.1186/1471-2334-14-s7-o11 |
| Popis: | Background Inactive HBV carriers, under immunosuppressive treatment for malignancies or rheumatologic diseases, have an increased risk for HBV reactivation. HBV reactivation under immunosuppression has a high rate of acute liver failure and death. HBV screening is mandatory for patients with hematological malignancies or rheumatologic diseases who are due to receive immunosuppressive treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink